Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + GTP
2 diphosphate + cyclic 3',5'-AMP-GMP
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
additional information
?
-
ATP + GTP

2 diphosphate + cyclic 3',5'-AMP-GMP
-
-
-
?
ATP + GTP
2 diphosphate + cyclic 3',5'-AMP-GMP
cyclic 3',5'-AMP-GMP is a signalling molecule in mammalian cells that triggers the production of type I interferons and other cytokines
-
-
?
ATP + GTP
2 diphosphate + cyclic 3',5'-AMP-GMP
-
-
-
?
ATP + GTP
2 diphosphate + cyclic 3',5'-AMP-GMP
cyclic 3',5'-AMP-GMP is a signalling molecule in mammalian cells that triggers the production of type I interferons and other cytokines
-
-
?
ATP + GTP

2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
-
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
product is cyclic Gp(2'-5')Ap(3'-5')
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
product is cyclic Gp(2'-5')Ap(3'-5')
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
over 78% conversion within 40 min
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
additional information

?
-
interaction of cGAS and viral DNA sensor IFI16, the pyrin domain of IFI16 mediates the interaction with ND10 bodies and enzyme cGAS
-
-
-
additional information
?
-
-
interaction of cGAS and viral DNA sensor IFI16, the pyrin domain of IFI16 mediates the interaction with ND10 bodies and enzyme cGAS
-
-
-
additional information
?
-
a diphosphatase-coupled cGAS activity assay is performed
-
-
-
additional information
?
-
-
a diphosphatase-coupled cGAS activity assay is performed
-
-
-
additional information
?
-
quantification of cyclic Gp(2'-5')Ap(3'-5')(2',3'-cGAMP)WS is performed by LC-MS/MS
-
-
-
additional information
?
-
the substrate orientation is thermodynamically preferred for 2',3'-cGAMP, kinetics, overview. cGAS can produce 2',3'-cGAMP without releasing AMP-2'-GTP to solution. AMP-2'-GTP is produced in significant abundance initially, while 2',3'-cGAMP is not
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP + GTP
2 diphosphate + cyclic 3',5'-AMP-GMP
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
additional information
?
-
ATP + GTP

2 diphosphate + cyclic 3',5'-AMP-GMP
cyclic 3',5'-AMP-GMP is a signalling molecule in mammalian cells that triggers the production of type I interferons and other cytokines
-
-
?
ATP + GTP
2 diphosphate + cyclic 3',5'-AMP-GMP
cyclic 3',5'-AMP-GMP is a signalling molecule in mammalian cells that triggers the production of type I interferons and other cytokines
-
-
?
ATP + GTP

2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
-
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
-
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
over 78% conversion within 40 min
-
-
?
ATP + GTP
2 diphosphate + cyclic Gp(2'-5')Ap(3'-5')
overall reaction
-
-
?
additional information

?
-
interaction of cGAS and viral DNA sensor IFI16, the pyrin domain of IFI16 mediates the interaction with ND10 bodies and enzyme cGAS
-
-
-
additional information
?
-
-
interaction of cGAS and viral DNA sensor IFI16, the pyrin domain of IFI16 mediates the interaction with ND10 bodies and enzyme cGAS
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1R,2S)-2-(7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carboxamido)cyclohexane-1-carboxylic acid
-
(3R)-1-(pyrrolo[1,2-a]quinoxalin-4-yl)piperidine-3-carboxylic acid
16.8% inhibition at 0.1 mM
(4-amino-6-((4-fluorophenyl)(methyl)amino)-1,3,5-triazin-2-yl)methanol
-
(4-amino-6-((4-fluorophenyl)amino)-1,3,5-triazin-2-yl)methanol
-
1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinoline-6,7-dicarboxylic acid
39.9% inhibition at 0.1 mM
1-[9-(6-aminopyridin-3-yl)-6,7-dichloro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl]-2-hydroxyethan-1-one
3-[1-(6,7-dichloro-1H-benzimidazol-2-yl)-5-hydroxy-3-methyl-pyrazol-4-yl]-3H-isobenzofuran-1-one
-
3-[5-(carboxymethyl)-3-oxo-3,5-dihydro[1,2,4]triazino[2,3-a]benzimidazol-2-yl]propanoic acid
29.9% inhibition at 0.1 mM
4,6-dichloro-N-(4-fluorophenyl)-1,3,5-triazin-2-amine
-
4-(dimethylamino)-6-((4-fluorophenyl)amino)-1,3,5-triazine-2-carbonitrile
-
4-amino-6-((4-fluorophenyl)amino)-N-methyl-1,3,5-triazine-2-carboxamide
-
4-amino-6-((4-iodophenyl)amino)-1,3,5-triazine-2-carboxylicacid
-
4-amino-6-(4-fluoroanilino)-1,3,5-triazine-2-carboxylic acid
-
4-amino-N-benzyl-6-((4-fluorophenyl)amino)-1,3,5-triazine-2-carboxamide
-
4-[(4-fluorophenyl)amino]-6-(methylamino)-1,3,5-triazine-2-carbonitrile
-
4-[2-(2-methyl[1,2,4]triazolo[1,5-c]quinazolin-5-yl)hydrazinyl]-4-oxobutanoic acid
21.8% inhibition at 0.1 mM
6-((4-fluorophenyl)amino)pyrimidine-4-carboxylic Acid
-
6-(1H-benzo[d]imidazol-1-yl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
-
6-(1H-indazol-1-yl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
-
6-(1H-indol-1-yl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
-
6-(4-(2-aminophenyl)-1H-1,2,3-triazol-1-yl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
-
6-(4-(4-fluorophenyl)-1H-1,2,3-triazol-1-yl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
-
6-(aminomethyl)-N2-(4-fluorophenyl)-1,3,5-triazine-2,4-diamine
-
6-(azidomethyl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
-
6-chloro-N2-(4-fluorophenyl)-N4,N4-dimethyl-1,3,5-triazine-2,4-diamine
-
7-methoxy-N9-methyl-N9-[3-[methyl(pyridin-4-yl)amino]propyl]acridine-3,9-diamine
9-amino-6-chloro-2-methoxyacridine
-
antimalarial drug, inhibits dsDNA stimulation of cGAS. IC50 value for interferon IFN-beta 0.0053 mM
methyl 3-amino-5-((4-fluorophenyl)amino)benzoate
-
methyl 4-(dimethylamino)-6-((4-fluorophenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((2-iodophenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((3,4,5-trifluorophenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((4-(trifluoromethyl)phenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((4-ethynylphenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((4-fluorophenyl)(methyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((4-fluorophenyl)amino)picolinate
-
methyl 4-amino-6-((4-hydroxyphenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((4-iodophenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-((4-methoxyphenyl)amino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-(3,5-difluoro-4-iodoanilino)-1,3,5-triazine-2-carboxylate
i.e. CU-76, selectively inhibits the DNA pathway in human cells but has no effect on the RIG-I-MAVS or Toll-like receptor pathways
-
methyl 4-amino-6-(4-iodoanilino)-1,3,5-triazine-2-carboxylate
i.e. CU-32, selectively inhibits the DNA pathway in human cells but has no effect on the RIG-I-MAVS or Toll-like receptor pathways
-
methyl 4-amino-6-(phenylamino)-1,3,5-triazine-2-carboxylate
-
methyl 4-amino-6-[(3,5-difluoro-4-iodophenyl)amino]-1,3,5-triazine-2-carboxylate
-
methyl 4-[(4-fluorophenyl)amino]-6-(methylamino)-1,3,5-triazine-2-carboxylate
-
N-2-(4-iodophenyl)-6-(1,3,4-oxadiazol-2-yl)-1,3,5-triazine-2,4-diamine
-
N-[2-(1-(4-amino-6-[(4-iodophenyl)amino]-1,3,5-triazin-2-yl)-1H-1,2,3-triazol-4-yl)phenyl]methanesulfonamide
-
N2-(4-fluorophenyl)-6-(methoxymethyl)-1,3,5-triazine-2,4-diamine
-
N2-(4-iodophenyl)-6-(1H-pyrazol-1-yl)-1,3,5-triazine-2,4-diamine
-
Quinacrine
-
antimalarial drug, inhibits dsDNA stimulation of cGAS. IC50 value for interferon IFN-beta 0.0037 mM
(1R,2S)-2-(7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carboxamido)cyclohexane-1-carboxylic acid

PF-06928215, a commercial inhibitor, enzyme binding structure analysis, the pyrazolopyrimidine of PF-06928215 is sandwiched between the guanidinium group of R376 and the aromatic ring of Y436, mimicking the nucleobase. The benzene is anchored in a hydrophobic subpocket lined by the side chains of F488 and L490, molecular dynamics simulations, overview
-
(1R,2S)-2-(7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carboxamido)cyclohexane-1-carboxylic acid
PF-06928215, a commercial inhibitor
-
1-[9-(6-aminopyridin-3-yl)-6,7-dichloro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl]-2-hydroxyethan-1-one

-
1-[9-(6-aminopyridin-3-yl)-6,7-dichloro-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl]-2-hydroxyethan-1-one
-
-
3-[1-(6,7-dichloro-1H-benzimidazol-2-yl)-5-hydroxy-3-methyl-pyrazol-4-yl]-3H-isobenzofuran-1-one

RU-521 or RU.521
-
3-[1-(6,7-dichloro-1H-benzimidazol-2-yl)-5-hydroxy-3-methyl-pyrazol-4-yl]-3H-isobenzofuran-1-one
-
RU-521 or RU.521
-
3-[1-(6,7-dichloro-1H-benzimidazol-2-yl)-5-hydroxy-3-methyl-pyrazol-4-yl]-3H-isobenzofuran-1-one
RU-521 or RU.521
-
3-[1-(6,7-dichloro-1H-benzimidazol-2-yl)-5-hydroxy-3-methyl-pyrazol-4-yl]-3H-isobenzofuran-1-one
RU-521 or RU.521, markedly mitigates the inflammatory responses, oxidative stress and apoptosis in hearts of sepsis mice. RU.521 attenuates myocardial apoptosis in the hearts of mice with sepsis
-
7-methoxy-N9-methyl-N9-[3-[methyl(pyridin-4-yl)amino]propyl]acridine-3,9-diamine

-
7-methoxy-N9-methyl-N9-[3-[methyl(pyridin-4-yl)amino]propyl]acridine-3,9-diamine
-
-
additional information

in silico screening-based discovery of inhibitors of human cyclic GMP-AMP synthase, cross-validation study of molecular docking and experimental testing, usage of catalytic domain of human cGAS (h-cGASCD) for virtual screening, overview
-
additional information
-
in silico screening-based discovery of inhibitors of human cyclic GMP-AMP synthase, cross-validation study of molecular docking and experimental testing, usage of catalytic domain of human cGAS (h-cGASCD) for virtual screening, overview
-
additional information
discovery of small-molecule cyclic GMP-AMP synthase inhibitors, sceening and molecular docking study using structure PDB ID 4O6A, overview
-
additional information
-
discovery of small-molecule cyclic GMP-AMP synthase inhibitors, sceening and molecular docking study using structure PDB ID 4O6A, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0039
(4-amino-6-((4-fluorophenyl)(methyl)amino)-1,3,5-triazin-2-yl)methanol
Homo sapiens
pH 7.5, 37°C
0.0043
(4-amino-6-((4-fluorophenyl)amino)-1,3,5-triazin-2-yl)methanol
Homo sapiens
pH 7.5, 37°C
0.00059
4-amino-6-((4-iodophenyl)amino)-1,3,5-triazine-2-carboxylicacid
Homo sapiens
pH 7.5, 37°C
0.0038
4-amino-6-(4-fluoroanilino)-1,3,5-triazine-2-carboxylic acid
Homo sapiens
pH 7.5, 37°C
0.00023
6-(4-(2-aminophenyl)-1H-1,2,3-triazol-1-yl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
Homo sapiens
pH 7.5, 37°C
0.0023
6-(aminomethyl)-N2-(4-fluorophenyl)-1,3,5-triazine-2,4-diamine
Homo sapiens
pH 7.5, 37°C
0.1
6-(azidomethyl)-N2-(4-iodophenyl)-1,3,5-triazine-2,4-diamine
Homo sapiens
pH 7.5, 37°C
0.032
9-amino-6-chloro-2-methoxyacridine
Homo sapiens
-
pH 7.5, 22°C
0.0131
methyl 4-amino-6-((2-iodophenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.00024 - 0.00027
methyl 4-amino-6-((3,4,5-trifluorophenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.0149
methyl 4-amino-6-((4-(trifluoromethyl)phenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.0014
methyl 4-amino-6-((4-ethynylphenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.0087
methyl 4-amino-6-((4-hydroxyphenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.00045 - 0.00066
methyl 4-amino-6-((4-iodophenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.0045
methyl 4-amino-6-((4-methoxyphenyl)amino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.005
methyl 4-amino-6-(phenylamino)-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.0015
methyl 4-amino-6-[(3,5-difluoro-4-iodophenyl)amino]-1,3,5-triazine-2-carboxylate
Homo sapiens
pH 7.5, 37°C
0.0025
N-2-(4-iodophenyl)-6-(1,3,4-oxadiazol-2-yl)-1,3,5-triazine-2,4-diamine
Homo sapiens
pH 7.5, 37°C
0.0034
N2-(4-iodophenyl)-6-(1H-pyrazol-1-yl)-1,3,5-triazine-2,4-diamine
Homo sapiens
pH 7.5, 37°C
0.013
Quinacrine
Homo sapiens
-
pH 7.5, 22°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.